Clinical trials: Positive Predictive Value
Breast Neoplasms
Comparison of Diagnostic Performance of Digital Breast Tomosynthesis and Ultrasound in Women With Dense Breasts
Diagnostic performance of digital breast tomosynthesis (DBT) would be not inferior to the that of breast ultrasound in women with dense breast.
- Trial name
- NCT01910103
- Where
- South Korea
- Volunteers
- 825 people, healthy volunteers welcome
- Sponsor
- Seoul National University Hospital
Schizophrenia
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
Background: The aims of this study were to explore the relationship between early reduction in psychotic symptoms and the ultimate response in patients with schizophrenia treated by atypical antipsychotics, and to determine the…
- Trial name
- NCT03730857
- Testing
- Olanzapine, risperidone, Paliperidone
- Volunteers
- 111 people, healthy volunteers welcome
- Sponsor
- Calo Psychiatric Center
Chronic Myeloid Leukemia
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia
The purpose of this study is to find out if the level of imatinib in the bloodstream, and the level that leukemia cells will predict how quickly your chronic myeloid leukemia improves with the treatment.
- Trial name
- OCT-1 (NCT00947830)
- Where
- Canada
- Volunteers
- 81 people
- Sponsor
- Brian Leber
Malignant Glioma
Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas
The aim of the present Phase III study is to assess the positive predictive value of NPC-07 (5-aminolevulinic acid hydrochloride) induced tissue fluorescence, safety and pharmacokinetics following a single dose of NPC-07 orally…
- Trial name
- NCT01167322
- Testing
- NPC-07 for oral administration
- Where
- 3 sites in Japan
- Volunteers
- 45 people
- Sponsor
- Nobelpharma
DFNA9, Sensorineural Hearing Loss
Artificial Intelligence in Diagnosis of DFNA9
To study the positive predictive value of Audiogene v.4.0 open source online machine learning tool in accurately predicting DFNA9 (DeaFNess autosomal dominant ninth) as top 3 gene loci in a large series of genetically confirmed…
- Trial name
- DFNA9 (NCT04331015)
- Testing
- Pure tone audiometry
- Where
- 2 sites in Belgium
- Volunteers
- 111 people
- Sponsor
- Jessa Hospital
Breast Cancer Female, Stage II Breast Cancer
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
This is a prospective and observational study, aiming to determine the detection rate and change of CtDNA in blood samples of cancer patients before, during and after neoadjuvant treatment.
- Conditions
- Breast Cancer Female, Stage II Breast Cancer, Stage III Breast Cancer, HER2-positive Breast Cancer
- Trial name
- BRAVA (NCT06087120)
- Where
- 3 sites in Indonesia, Vietnam
- Volunteers
- 125 people
- Sponsor
- Gene Solutions
Wounds
Positive Predictive Value of the MolecuLight i:X Imaging Device to Predict the Presence of Bacteria in Chronic Wounds
This is a non-randomized evaluation for which 50 patients will be imaged at the Southwest Regional Wound Care Center, Lubbock, Texas, who present with a chronic wound and are receiving standard treatment.
- Trial name
- NCT02682069
- Testing
- MolecuLight i:X Imaging Device
- Volunteers
- 30 people
- Sponsor
- MolecuLight Inc.
Pulmonary Embolism
Adrenomedullin in Context With Pulmonary Embolism
The pulmonary embolism (PE) causes a blockade of the pulmonary arteries typical due to a thrombus which is formed in the lower region of the body or pretty rare to other materials (tumor, air, fat).
- Trial name
- NCT04875130
- Testing
- blood samples
- Where
- 2 sites in Austria, Hungary
- Volunteers
- 24 people
- Sponsor
- University of Pecs
Chronic Myeloid Leukemia
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
Imatinib (IM) is first-line treatment for patients with newly diagnosed CML in chronic phase. The drug is associated with high rates of cytogenetic responses with minimal toxicity in approximately 80% of patients.
- Trial name
- NCT01215487
- Testing
- Stem Cell and Mutational Assay
- Where
- Canada
- Volunteers
- 68 people
- Sponsor
- University of British Columbia
Tuberculin Skin Test
Self-Assessment Tuberculin Skin Test
The research team/investigator/nurse/professional health care workers will teach the participants how to read the results for TST test.
- Trial name
- ISAT (NCT03835832)
- Testing
- The participants do not receive any intervention for this study
- Where
- 2 sites in Thailand
- Volunteers
- 215 people
- Sponsor
- The HIV Netherlands Australia Thailand Research Collaboration